Intracranial Pressure (ICP) Monitoring Market Research Report: Information by Route of Intervention (Intraventricular and Epidural Sensor), Technique (Invasive and Non-Invasive), Application (Traumatic Brain Injury and Subarachnoid Hemorrhage), Device (Intraventricular Catheter and Epidural Sensors), End-User (Hospitals and Clinics, Trauma Centers and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast Till 2027
ID: MRFR/MED/0232-CR | August 2019 | Region: Global | 129 pages
Intracranial Pressure (ICP) Monitoring Market Overview
The Global Intracranial Pressure (ICP) Monitoring Market is expected to register 7.1% CAGR and is projected to reach USD 2,013.9 Million by 2024. Intracranial pressure monitoring devices are designed to measure the pressure within the cranium caused by trauma and accident. It is majorly used in treating traumatic brain injury.
Neurovascular diseases affect the cerebral vascular system and the spinal cord. Neurovascular diseases are inclusive of aneurysms, Dural arteriovenous fistula, Arteriovenous Malformation (AVM angioma), cavernoma, and cerebral hemorrhage. These diseases can be effectively treated by the application of ICP monitoring devices.
Market Dynamics
Increasing prevalence of neurovascular diseases, such as brain aneurysms and Arteriovenous Malformations (AVMs), is likely to propel the global ICP monitoring market. The global burden of neurovascular diseases is increasing. This marks the increase in healthcare expenditures, boosting the demand for therapeutics. Developing countries in Asia-Pacific represent untapped markets in the presence of increasing patient population and the growing healthcare sector. These prevailing conditions are likely to boost the market growth. However, the high cost of ICP monitoring devices along with treatment procedures, is expected to retrain the market growth during the forecast period.
Global Intracranial Pressure (ICP) Monitoring Market Size, by Route of Intervention, 2017 (USD Million) 
Source: MRFR Analysis
Segmentation
The global intracranial pressure (ICP) monitoring market has been segmented into route of intervention, technique, application, device, and end user.
By route of intervention, the global market is segmented into intraventricular, epidural sensor, and others. The standard technique of ICP monitoring is to insert the catheter into the ventricle of the brain. The catheter drains the Cerebrospinal Fluid (CSF) as well as monitors the intracranial pressure. Epidural ICP monitoring does not offer accurate results but is less invasive techniques than others.
Based on technique, the global market has been divided into invasive and non-invasive. The invasive segment is further categorized into transcranial doppler ultrasonography, tympanic membrane displacement (TMD) analyzer, optic nerve sheath diameter sonography, fundoscopy (papilledema), and MRI/CT. Invasive techniques require a high level of expertise and have clinically significant risks, including hemorrhage, infection, and probe displacement. Non-invasive tools could circumvent these limitations, allowing detailed investigations and management of elevated intracranial pressure.
Based on application, the global market is further segmented into traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, and others. Traumatic brain injury is the most common cause of death and disability in the Americas. According to the Centers for Disease Control and Prevention, in 2017, 30% of all injury deaths are due to traumatic brain injury in the US.
Based on device, the global market is segmented into intraventricular catheters, subarachnoid screws, fiber-optic monitors, epidural sensors, and non-invasive ICP monitors. The intraventricular catheter segment held the largest market share in 2017 and is estimated to reach USD 922.7 Million by 2024 from USD 559.1 million in 2017.
Based on end user, the global market is segmented into hospitals and clinics, trauma centers, and others. The hospitals and clinics segment dominates the global market for Intracranial Pressure (ICP) monitoring and is projected to reach USD 1299.5 million by the end of 2024.
Key Players
The major players in the global intracranial pressure (ICP) monitoring market are Integra LifeSciences Corporation (US), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), RAUMEDIC Inc. (Germany), Sophysa SA (France), Boston Neurosciences (US), Medtronic Plc (Ireland), Terumo Corporation (US) and Natus Medical Incorporated (US).
These players are adopting various strategies to expand their global ICP business and enhance their market share.
Global Intracranial Pressure (ICP) Monitoring Market Share, by Region, 2017 (%) 
Source: MRFR Analysis
Regional Analysis
The global intracranial pressure (ICP) monitoring market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas accounted for the largest market share and is estimated to dominate the global intracranial pressure (ICP) monitoring market. The region holds the largest market share and is expected to reach USD 844.8 million by 2024. The Americas accounts for the largest regional market owing to technological advancements in medical devices and a well-developed healthcare system, along with the increasing number of traumatic brain injuries.
Europe accounted for the second-largest market share in 2017. High blood pressure increases the risk of a brain hemorrhage. According to Public Health England, around 12.5 million people in 2015 suffered from high blood pressures in the UK. This provides favorable backgrounds for the market to grow in the region.
Asia-Pacific is expected to witness a lucrative CAGR of about 7.4% during the forecast period owing to the presence of rapidly growing economies such as China, Japan, and India. However, the Middle East and Africa is expected to observe slow growth due to less exposure to healthcare services and stringent government rules and regulations
Key Updates
- In July 2016, Terumo Corporation agreed to purchase Sequent Medical, Inc., a privately-held firm developing a new medical device for aneurysm embolization, thus, expanding its portfolio of neurovascular products.
- In September 2017, Natus Medical Incorporated acquired neurosurgery business assets from Integra LifeSciences, entering into the neurosurgery business segment.
- In April 2018, Medtronic plc announced two-year outcomes for the Harmony (TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study. The study was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 41st Annual Scientific Sessions.
Market Segmentation
Global Intracranial Pressure (ICP) Monitoring Market, by Route of Intervention
- Intraventricular
- Epidural Sensor
Global Intracranial Pressure (ICP) Monitoring Market, by Technique
- Invasive
- Non-invasive
- Transcranial Doppler Ultrasonography
- Tympanic Membrane Displacement (TMD) Analyzer
- Optic Nerve Sheath Diameter Sonography
- Fundoscopy (Papilledema)
- MRI/CT
Global Intracranial Pressure (ICP) Monitoring Market, by Application
- Traumatic Brain Injury
- Intracerebral Hemorrhage
- Subarachnoid Hemorrhage
- Meningitis
Global Intracranial Pressure (ICP) Monitoring Market, by Device
- Intraventricular catheter
- Subarachnoid screw
- Non-invasive ICP monitors
- Epidural sensors
Global Intracranial Pressure (ICP) Monitoring Market, by End User
- Hospitals & Clinic
- Trauma Centers
Global Intracranial Pressure (ICP) Monitoring Market, by Region
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
- Rest of Middle East & Africa
Available Additional Customizations
- Additional Companies
- Siemens Healthcare Private Limited
- Advanced Brain Monitoring
- Compumedics Limited
- Orsan Medical Technologies Ltd.
- NIHON KOHDEN CORPORATION
Intended Audience
- Trauma centers
- Research and academic institutes
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
Frequently Asked Questions (FAQ) :
The projected CAGR would be 7.1% during the forecast period.
The market valuation would be USD 2013.9 million by 2024.
The intraventricular catheter segment would continue its dominance until 2027.
The hospitals & clinics segment would lead the market in the coming years.
The Americas would dominate the global Intracranial Pressure (ICP) Monitoring Market.
Intracranial Pressure Monitoring Market – Summary
Overview:
Time is of the essence when it comes to traumatic brain injuries. Constant monitoring of the intracranial pressure (ICP) is needed to avoid anything fatal. The idea is to measure cerebrospinal fluid (CSF) pressure with a small pressure-sensitive probe directly inserted through the skull. Constant monitoring, especially during sleep, is necessary to determine abnormalities and its connection with symptoms. The global intracranial pressure monitoring market can expect a substantial 7.1 % CAGR during the forecast period (2018-2024), asserts Market Research Future (MRFR). In their holistic take on the intracranial pressure monitoring market, MRFR included several factors that can substantially influence the market before dissecting various segments in detail for better predictive analysis.
Neurovascular diseases such as a brain aneurysm, and arteriovenous malformations (AVM) are getting much prominence. A blend of both, occurrence and awareness, regarding such diseases, is working in favor of the intracranial pressure monitoring market. Furthermore, healthcare expenditures in developed countries are on the rise giving therapeutics proper foothold. Meanwhile, developing countries, with revamped healthcare sector and increased health-related awareness, are opening up as an untapped market with massive opportunities for the intracranial pressure monitoring market expansion.
Reimbursing policies of governments are playing a crucial role in providing patients with holistic care. Worrying over payment, in most cases, is no longer an option. At the same time, reimbursements give patients the opportunity to cure their diseases from the root. In the U.S. alone, a 2015 report of the American Hospital Association reveals, 88% of the Medicare patients and 90% of the Medicaid patients have been reimbursed. Patients can always take it as a head start. At the same time, the rising number of traumatic brain injuries are raising quite a few eyebrows. Reports published by the Centers for Disease Control and Prevention (CDC) in 2017, North America has suffered more than 1.75 million traumatic brain injuries. Only timely interventions from skilled physicians can deliver a favorable result. Advances in technology have empowered doctors, and a perfect example would be ICP monitoring. Revamped healthcare sectors across the globe have realized its importance and are incorporating the system into their infrastructure.
But the market is not without its fair share of uphill tasks. Devices associated with intracranial pressure monitoring incur a high procedural cost which many prefer to avoid. At the same time, the market is hit by a severe shortage of skilled professionals which could brew troubles for the normal market growth during the forecast period.
Industry Opportunity:
Endovascular embolization is a treatment perfect for brain aneurysms where natural access through the bloodstream is necessary. However, it requires monitoring of the intracranial function at every step. A rise in such procedure can trigger growth in the intracranial pressure monitoring market as well.
After the hiccups, experienced between 2014-2016, the global GDP is recovering which means healthcare sector is also going to experience substantial growth. This is already visible in various sub-segments of the healthcare industry and intracranial pressure monitoring I no exception.
Segmentation:
By route of intervention, the ICP monitoring can be segmented into intraventricular, epidural sensor, and others. Among these, intraventricular is expecting the largest leap by 7.4% CAGR during the forecast period from USD 774.5 million in 2018 to USD 1,190 million by 2024. The next in line would be an epidural sensor with a market projection of USD 678.5 million valuation.
By technique, the ICP monitoring market can be segmented into invasive and non-invasive. Invasive segment can enjoy a robust growth by 7.1% CAGR during the review period and reach USD 1,979 million by 2024 from USD 1,310.7 million valuation of 2018.
Based on application, the ICP monitoring market includes traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage, meningitis, and others. With a 7.5% CAGR during the review period, the highest among the sub-segments, traumatic brain injury is expected to lead the market from the front. Its valuation would go up to USD 1,141.8 million by 2024 from USD 741.1 million of 2018 during the forecast period.
Device-wise, the ICP monitoring market comprises intraventricular catheter, subarachnoid screw, non-invasive ICP monitor, epidural sensors, and others. Intraventricular catheter’s growth will be substantial, and it would reach USD 922.7 million by 2024 from USD 600.6 million with a 7.4% CAGR during the assessment period.
Based on end-users, the ICP monitoring market can be segmented into hospitals & clinics, trauma centers, and others. With an expected market valuation of USD 1,299.5 million by 2024 and an astonishing CAGR of 7.4% during the forecast period, the segment is going to dominate. Trauma centers are touted to grow with 7.2% CAGR during the review period.
Regional Analysis:
Geographically, the intracranial pressure monitoring market includes the Americas, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).
The Americas can expect the highest market growth during the forecast period. Its expected CAGR will hover around 7.3% CAGR during the forecast period, and the regional market can easily scale to a valuation of USD 844.8 million by 2024. Superior infrastructure and substantial healthcare investment are driving the market further ahead. At the same time, the region can boast of significant technological advancement.
Europe assumes the second spot with a considerable market share of USD 445.7 million which could go up and create a market value of USD 676.7 million with a 7.2% CAGR during the forecast period. Healthcare setup of the region is quite similar to that of the Americas, and government investment and funding can take the market to new heights.
The APAC, owing to an upheaval in the healthcare sector can now expect a steady rise to a valuation of USD 420.6 million during the forecast period. The rise would be better than the rest, and the anticipated CAGR would be of 7.4% during the forecast period.
The MEA will have slow and steady growth. Lack of infrastructure is bogging the market down, and a meager 2.6% CAGR can be expected from this region.
Market Landscape:
The oligopolistic market of the intracranial pressure monitoring is experiencing several strategic implementations with leading companies getting involved in the tactical collaboration, mergers, acquisitions, and new product launches. For instance, Terumo Corporation has bought Sequent Medical, Inc, a company that develops new devices for aneurysm embolization. On the other hand, Natus Medical Incorporated has acquired the neurosurgery business wing from Integra LifeSciences which can be considered exemplary.
Key companies operating in the intracranial pressure monitoring market are Integra LifeSciences Corporation, DePuy Synthes, Spiegelberg GmbH & Co.KG, RAUMEDIC Inc., Sophysa SA, Boston Neurosciences, Medtronic Plc., Terumo Corporation, Natus Medical Incorporated, and others.
1 Report Prologue
2 Market Introduction
2.1 Scope Of Study 17
2.2 Research Objective 17
2.3 List Of Assumptions 18
2.4 Market Structure 18
3 Research Methodology
3.1 Research Process 20
3.2 Primary Research 21
3.3 Secondary Research 22
3.4 Market Size Estimation 23
3.5 Forecast Model 23
4 Market Dynamics
4.1 Introduction 25
4.2 Drivers 25
4.2.1 Increasing Prevalence Of Neurovascular Diseases, Such As Brain Aneurysm, Arteriovenous Malformations (AVMs), And Others, Are Likely To Propel The ICP Monitoring Market 25
4.2.2 Favourable Reimbursement Policies Provide Favourable Background For The Market Growth 26
4.2.3 Growing Prevalence Of Traumatic Brain Injuries 26
4.2.4 Ongoing Product Development & Commercialization Will Boost The ICP Monitoring Market 26
4.3 Restraints 27
4.3.1 The Shortage Of Trained Professionals 27
4.3.2 High Procedural Cost Of ICP Monitoring Devices 27
4.4 Opportunities 27
4.4.1 Increasing Use Of Endovascular Embolization For The Treatment Of Brain Aneurysm 27
4.5 Macroeconomic Indicators 28
5 Market Factor Analysis
5.1 Value Chain Analysis 30
5.1.1 R&D & Designing 30
5.1.2 Manufacturing 30
5.1.3 Distribution & Sales 31
5.1.4 Post-Sales Review 31
5.2 Porter’s Five Forces Model 31
5.2.1 Bargaining Power Of Suppliers 32
5.2.2 Bargaining Power Of Buyers 32
5.2.3 Threat Of New Entrants 32
5.2.4 Threat Of Substitutes 33
5.2.5 Intensity Of Rivalry 33
5.3 Re-Operation Rate Analysis 33
5.4 Complication Rate Analysis 33
6 Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
6.1 Introduction 35
6.2 Intraventricular 36
6.3 Epidural Sensor 36
7 Intracranial Pressure (ICP) Monitoring Market, By Technique
7.1 Introduction 38
7.2 Invasive 39
7.3 Non-Invasive 39
7.3.1 Transcranial Doppler Ultrasonography 39
7.3.2 Tympanic Membrane Displacement (TMD) Analyzer 39
7.3.3 Optic Nerve Sheath Diameter Sonography 40
7.3.4 Fundoscopy (Papilledema) 40
7.3.5 MRI/CT 40
8 Intracranial Pressure (ICP) Monitoring Market, By Application
8.1 Introduction 42
8.2 Traumatic Brain Injury 43
8.3 Intracerebral Hemorrhage 43
8.4 Subarachnoid Hemorrhage 43
8.5 Meningitis 44
9 Intracranial Pressure (ICP) Monitoring Market, By Device
9.1 Introduction 46
9.2 Intraventricular Catheter 47
9.3 Subarachnoid Screw 47
9.4 Non-Invasive ICP Monitors 47
9.5 Epidural Sensors 48
10 Intracranial Pressure (ICP) Monitoring Market, By End User
10.1 Introduction 50
10.2 Hospitals & Clinic 51
10.3 Trauma Centers 51
11 Global Intracranial Pressure (ICP) Monitoring Market, By Region
11.1 Introduction 53
11.2 Americas 54
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.2.1 North America 56
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.2.1.1 US 59
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.2.1.2 Canada 61
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.2.2 South America 63
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3 Europe 65
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.1 Western Europe 68
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.1.1 Germany 70
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.1.2 France 72
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.1.3 UK 74
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.1.4 Italy 76
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.1.5 Spain 78
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.1.6 Rest Of Western Europe 80
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.3.2 Eastern Europe 83
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.4 Asia-Pacific 85
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.4.1 Japan 87
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.4.2 China 89
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.4.3 India 91
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.4.4 Australia 93
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.4.5 Rest Of Asia-Pacific 95
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.5 Middle East & Africa 98
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.5.1 Middle East 100
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.5.2 Africa 102
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
11.5.3 Rest Of Middle East & Africa 104
Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention
Intracranial Pressure (ICP) Monitoring Market, By Technique
Intracranial Pressure (ICP) Monitoring Market, By Application
Intracranial Pressure (ICP) Monitoring Market, By Device
Intracranial Pressure (ICP) Monitoring Market, By End User
12 Competitive Landscape
12.1 Company Market Share Analysis 108
12.1.1 Introduction 108
12.2 Competitive Landscape 109
12.2.1 Introduction 109
12.3 Key Developments 110
13 Company Profiles
13.1 Integra LifeSciences Corporation 112
13.1.1 Company Overview 112
13.1.2 Financial Overview 112
13.1.3 Products Offered 113
13.1.4 Key Developments 113
13.1.5 SWOT Analysis 113
13.1.6 Key Strategies 113
13.2 DePuy Synthes 114
13.2.1 Company Overview 114
13.2.2 Financial Overview 114
13.2.3 Products Offered 115
13.2.4 Key Developments 115
13.2.5 SWOT Analysis 115
13.2.6 Key Strategies 115
13.3 Spiegelberg GmbH & Co. KG 116
13.3.1 Company Overview 116
13.3.2 Financial Overview 116
13.3.3 Products Offered 116
13.3.4 Key Developments 116
13.3.5 SWOT Analysis 116
13.3.6 Key Strategies 116
13.4 RAUMEDIC Inc 117
13.4.1 Company Overview 117
13.4.2 Financial Overview 117
13.4.3 Products Offered 117
13.4.4 Key Developments 117
13.4.5 SWOT Analysis 117
13.4.6 Key Strategies 117
13.5 Sophysa SA 118
13.5.1 Company Overview 118
13.5.2 Financial Overview 118
13.5.3 Products Offered 118
13.5.4 Key Developments 118
13.5.5 SWOT Analysis 118
13.5.6 Key Strategies 118
13.6 Boston Neurosciences 119
13.6.1 Company Overview 119
13.6.2 Financial Overview 119
13.6.3 Products Offered 119
13.6.4 Key Developments 119
13.6.5 SWOT Analysis 119
13.6.6 Key Strategies 119
13.7 Medtronic Plc 120
13.7.1 Company Overview 120
13.7.2 Financial Overview 120
13.7.3 Products Offered 121
13.7.4 Key Developments 121
13.7.5 SWOT Analysis 121
13.7.6 Key Strategies 121
13.8 Terumo Corporation 122
13.8.1 Company Overview 122
13.8.2 Financial Overview 122
13.8.3 Products Offered 123
13.8.4 Key Developments 123
13.8.5 SWOT Analysis 123
13.8.6 Key Strategies 123
13.9 Natus Medical Incorporated 124
13.9.1 Company Overview 124
13.9.2 Financial Overview 124
13.9.3 Products Offered 125
13.9.4 Key Developments 125
13.9.5 SWOT Analysis 125
13.9.6 Key Strategies 125
14 Appendix
14.1 Discussion Blue Print 127
15 List Of Tables
TABLE 1 LIST OF ASSUMPTIONS 18
TABLE 2 PRIMARY INTERVIEWS 20
TABLE 3 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 35
TABLE 4 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INTRAVENTRICULAR 2020–2027 (USD MILLION) 36
TABLE 5 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY EPIDURAL SENSOR 2020–2027 (USD MILLION) 36
TABLE 6 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 38
TABLE 7 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 39
TABLE 8 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE 2020–2027 (USD MILLION) 39
TABLE 9 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 42
TABLE 10 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TRAUMATIC BRAIN INJURY 2020–2027 (USD MILLION) 43
TABLE 11 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INTRACEREBRAL HEMORRHAGE 2020–2027 (USD MILLION) 43
TABLE 12 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY SUBARACHNOID HEMORRHAGE 2020–2027 (USD MILLION) 43
TABLE 13 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY MENINGITIS 2020–2027 (USD MILLION) 44
TABLE 14 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICE 2020–2027 (USD MILLION) 46
TABLE 15 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INTRAVENTRICULAR CATHETER 2020–2027 (USD MILLION) 47
TABLE 16 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY SUBARACHNOID SCREW 2020–2027 (USD MILLION) 47
TABLE 17 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY NON-INVASIVE ICP MONITORS 2020–2027 (USD MILLION) 47
TABLE 18 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY EPIDURAL SENSORS 2020–2027 (USD MILLION) 48
TABLE 19 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER 2020–2027 (USD MILLION) 50
TABLE 20 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY HOSPITALS & CLINIC 2020–2027 (USD MILLION) 51
TABLE 21 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TRAUMA CENTERS 2020–2027 (USD MILLION) 51
TABLE 22 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 53
TABLE 23 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 54
TABLE 24 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 54
TABLE 25 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 55
TABLE 26 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 55
TABLE 27 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 55
TABLE 28 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 56
TABLE 29 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 56
TABLE 30 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 56
TABLE 31 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 57
TABLE 32 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 57
TABLE 33 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 58
TABLE 34 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 58
TABLE 35 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 58
TABLE 36 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 59
TABLE 37 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 59
TABLE 38 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 59
TABLE 39 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 59
TABLE 40 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 60
TABLE 41 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 60
TABLE 42 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 60
TABLE 43 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 61
TABLE 44 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 61
TABLE 45 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 61
TABLE 46 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 62
TABLE 47 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 62
TABLE 48 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 62
TABLE 49 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 63
TABLE 50 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 63
TABLE 51 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 63
TABLE 52 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 64
TABLE 53 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 64
TABLE 54 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 64
TABLE 55 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 65
TABLE 56 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 65
TABLE 57 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 66
TABLE 58 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 66
TABLE 59 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 66
TABLE 60 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 67
TABLE 61 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 67
TABLE 62 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 68
TABLE 63 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 68
TABLE 64 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 69
TABLE 65 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 69
TABLE 66 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 69
TABLE 67 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 70
TABLE 68 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 70
TABLE 69 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 70
TABLE 70 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 71
TABLE 71 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 71
TABLE 72 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 71
TABLE 73 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 72
TABLE 74 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 72
TABLE 75 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 72
TABLE 76 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 73
TABLE 77 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 73
TABLE 78 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 73
TABLE 79 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 74
TABLE 80 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 74
TABLE 81 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 74
TABLE 82 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 75
TABLE 83 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 75
TABLE 84 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 75
TABLE 85 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 76
TABLE 86 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 76
TABLE 87 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 76
TABLE 88 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 77
TABLE 89 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 77
TABLE 90 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 77
TABLE 91 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 78
TABLE 92 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 78
TABLE 93 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 78
TABLE 94 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 79
TABLE 95 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 79
TABLE 96 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 79
TABLE 97 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 80
TABLE 98 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 80
TABLE 99 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 80
TABLE 100 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 81
TABLE 101 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 81
TABLE 102 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 81
TABLE 103 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 82
TABLE 104 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 82
TABLE 105 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 83
TABLE 106 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 83
TABLE 107 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 83
TABLE 108 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 84
TABLE 109 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 84
TABLE 110 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 84
TABLE 111 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 85
TABLE 112 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 85
TABLE 113 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 86
TABLE 114 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 86
TABLE 115 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 86
TABLE 116 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 87
TABLE 117 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 87
TABLE 118 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 87
TABLE 119 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 88
TABLE 120 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 88
TABLE 121 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 88
TABLE 122 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 89
TABLE 123 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 89
TABLE 124 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 89
TABLE 125 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 90
TABLE 126 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 90
TABLE 127 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 90
TABLE 128 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 91
TABLE 129 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 91
TABLE 130 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 91
TABLE 131 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 92
TABLE 132 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 92
TABLE 133 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 92
TABLE 134 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 93
TABLE 135 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 93
TABLE 136 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 93
TABLE 137 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 94
TABLE 138 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 94
TABLE 139 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 94
TABLE 140 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 95
TABLE 141 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 95
TABLE 142 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 95
TABLE 143 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 96
TABLE 144 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 96
TABLE 145 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 96
TABLE 146 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 97
TABLE 147 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 97
TABLE 148 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 98
TABLE 149 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 98
TABLE 150 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 99
TABLE 151 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 99
TABLE 152 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 99
TABLE 153 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 100
TABLE 154 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 100
TABLE 155 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 100
TABLE 156 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 101
TABLE 157 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 101
TABLE 158 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 101
TABLE 159 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 102
TABLE 160 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 102
TABLE 161 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 102
TABLE 162 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 103
TABLE 163 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 103
TABLE 164 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 103
TABLE 165 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 104
TABLE 166 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 104
TABLE 167 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 104
TABLE 168 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 105
TABLE 169 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 105
TABLE 170 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 105
TABLE 171 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 106
TABLE 172 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 106
TABLE 173 GLOBAL ICP MONITORINGS MARKET: KEY DEVELOPMENT 110
16 List Of Figures
FIGURE 1 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET: MARKET STRUCTURE 18
FIGURE 2 RESEARCH PROCESS 20
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 23
FIGURE 4 VALUE CHAIN: GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET 30
FIGURE 5 PORTER’S FIVE FORCES MODEL: GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET 32
FIGURE 6 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020&2027 35
FIGURE 7 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020&2027 38
FIGURE 8 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020&2027 42
FIGURE 9 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICE 2020&2027 46
FIGURE 10 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER 2020&2027 50
FIGURE 11 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 53
FIGURE 12 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 54
FIGURE 13 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 57
FIGURE 14 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 65
FIGURE 15 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 68
FIGURE 16 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 85
FIGURE 17 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 98
FIGURE 18 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, MARKET SHARE ANALYSIS 2020 (%) 108
FIGURE 19 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET COMPETITIVE LANDSCAPE (%) 109
Global Intracranial Pressure Monitoring (ICP) Monitoring Market: Competitive Landscape
The prominent players in the global intracranial pressure monitoring market are Integra LifeSciences, Codman & Shurtleff, Medtronic Plc, RAUMEDIC, Spiegelberg, Vittamed, and DePuy Synthes
Integra LifeSciences Corporation is the holds the largest share for the global intracranial pressure monitoring market in 2017. The company is an international leader in medical technology. The key focus of the company is to provide patients with a high level of satisfaction. The company also provides and operates innovative solutions in the field of orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. In the US, Integra LifeSciences Corporation is one of the leading players for providing surgical devices and instruments to various hospitals, surgery centers, physicians, and dental offices.
Natus Medical Incorporated supplies newborn care, neurology, and hearing and balance assessment healthcare products. It provides products and services used for the diagnosis, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. For instance, in Septmeber-2017, Natus Medical Incorporated acquired neurosurgery business assets from Integra LifeSciences, thus entering into the neurosurgery business segment.
Terumo Corporation manufactures and distributes medical devices and services worldwide. The company offers vascular intervention devices, such as introducer sheaths, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in 1974. For instance, in July 2016, Terumo Corporation entered into an agreement to purchase Sequent Medical, Inc., a privately-held firm developing a new medical device for aneurysm embolization, thus, expanding the portfolio of neurovascular products.
Medtronic Plc is a global healthcare solutions company committed to improving the lives of people through medical technologies, services, and solutions. Medtronics Plc with Covidien has accelerated and advanced its ability to create meaningful innovations for hospitals, health systems, and healthcare providers so that it can deliver the best care possible to patients and their families around the world. For instance, in April 2018, Medtronic plc announced two-year outcomes for the Harmony (TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study. The study was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 41st Annual Scientific Sessions.
Codman & Shurtleff and Integra LifeSciences are the major companies for ICP monitoring operating on a global scale. The lower market share of Johnson & Johnson Services Inc. can be attributed to fewer products offering, as compared to Sanofi S.A and other major players. Major players such as Medtronic Plc, RAUMEDIC, Spiegelberg, Vittamed, and DePuy Synthes, increase the level of competition in the global ICP monitoring market, as these companies are expected to expand their product portfolios, with the help of other business units, to increase their market share.
Four major players, namely, Integra LifeSciences, Codman & Shurtleff, Natus Medical Incorporated, and Medtronic Plc. account for more than three fourth share of the global Intracranial Pressure (ICP) monitoring market.
